CD8A and neoplasm: The novel technique leads to T cell‐dependent tumor progression along with increasing numbers and the function of CD4+, CD8+, NK cell, and M1 macrophage populations, while decreasing regulatory T cell, M2 macrophage, monocyte, neutrophil, and myeloid‐derived suppressor cell (MDSC) populations.